Exploratory data science methods and algorithm development in infectious and immune-mediated diseases (R21 clinical trial not allowed)
Summary text: This supports exploratory research focused on developing innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the infectious or immune-mediated disease research continuum. Awards are worth up to USD 275,000 each in direct costs over two years.